$-0.13 EPS Expected for Alphatec Holdings, Inc. (ATEC)

October 14, 2018 - By Clifton Ray

Alphatec Holdings, Inc. (NASDAQ:ATEC) Logo

Analysts expect Alphatec Holdings, Inc. (NASDAQ:ATEC) to report $-0.13 EPS on November, 8.They anticipate $0.09 EPS change or 40.91 % from last quarter’s $-0.22 EPS. After having $-0.21 EPS previously, Alphatec Holdings, Inc.’s analysts see -38.10 % EPS growth. The stock increased 3.73% or $0.11 during the last trading session, reaching $3.06. About 32,119 shares traded. Alphatec Holdings, Inc. (NASDAQ:ATEC) has risen 41.13% since October 14, 2017 and is uptrending. It has outperformed by 25.51% the S&P500.

Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, manufacture, and marketing of products for the surgical treatment of spine disorders. The company has market cap of $129.73 million. The Company’s product and procedural portfolio, as well as pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. It currently has negative earnings. The firm offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, XYcor Expandable Spinal Spacer System, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and thoracolumbar fixation products, such as Arsenal Degenerative, Arsenal Deformity, Arsenal CBx Cortical Bone Fixation, and Zodiac Degenerative Spinal Fixation systems.

More news for Alphatec Holdings, Inc. (NASDAQ:ATEC) were recently published by: Globenewswire.com, which released: “Alphatec Accelerates Organic Innovation Machine With Addition of Key Senior Leadership and Expansion of Market …” on September 27, 2018. Globenewswire.com‘s article titled: “Alphatec Advances Clinical Distinction With OsseoScrew® Clearance” and published on September 26, 2018 is yet another important article.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.